Muscle Repair & Anti-Inflammatories
Buy muscle repair and anti-inflammatory research compounds in Canada! BPC-157, TB-500, MK-2866 (Ostarine), Ipamorelin, Dexamethasone, Meloxicam, Diclofenac and more, shipped domestically from within Canada. Every compound is third party tested with a certificate of analysis on file. The most complete tissue repair and recovery research catalogue available from a domestic Canadian supplier.
Canada's most trusted domestic source for muscle repair and anti inflammatory research compounds. Peptide based tissue repair agents, selective anabolic compounds, corticosteroids, and NSAIDs. All sourced, tested, and dispatched same day from within Canada with no customs and no cross border delays.
Muscle Repair & Anti Inflammatory Compounds in Canada | Peptides, SARMs & Corticosteroids
Canada Steroid Depot's muscle repair and anti inflammatory category covers the most extensively researched compound classes for tissue repair, injury recovery, and inflammation management in anabolic and sports science research contexts. From peptide based tissue repair agents that modulate growth factor expression and angiogenesis, to selective anabolic compounds that preserve and restore muscle tissue during injury recovery, to corticosteroids and NSAIDs for acute inflammation management. CSD stocks the complete range of compounds used across these overlapping research areas.
Peptide tissue repair agents | BPC-157 and TB-500
BPC-157 (Body Protection Compound 157) and TB-500 (Thymosin Beta-4) are the two most extensively researched peptide compounds for musculoskeletal tissue repair. BPC-157 is a synthetic pentadecapeptide derived from human gastric juice protein, studied for its regenerative effects on tendon, ligament, muscle, bone, and gastrointestinal tissue through upregulation of growth hormone receptor expression, VEGF mediated angiogenesis, and nitric oxide system modulation. TB-500 is a synthetic analogue of Thymosin Beta-4, studied for its role in actin regulation, cell migration, angiogenesis, and inflammatory modulation. Producing systemic tissue repair effects particularly relevant to muscle and connective tissue injuries. Both are available individually and as a pre configured BPC-157 + TB-500 stack for synergistic tissue repair research.
MK-2866 (Ostarine) for muscle preservation during injury recovery
MK-2866 (Ostarine) is a selective androgen receptor modulator (SARM) with a strong anabolic profile in muscle and bone tissue with minimal androgenic activity in other tissues. It was originally developed by GTx Inc. for muscle wasting conditions and osteoporosis research. In injury recovery contexts, Ostarine is studied for its ability to preserve and restore lean muscle mass during periods of immobilisation or reduced training when muscle atrophy would otherwise occur rapidly. Its selective anabolic activity in muscle and bone without prostate, liver, or cardiovascular impacts makes it a particularly well suited compound for recovery phase muscle preservation research.
Corticosteroids | Dexamethasone and Methylprednisolone
Corticosteroids are potent anti inflammatory compounds that act by binding glucocorticoid receptors and suppressing the NF-κB inflammatory pathway. Reducing production of pro inflammatory cytokines, prostaglandins, and leukotrienes. Dexamethasone is the most potent and widely researched synthetic corticosteroid, with approximately 25x the anti inflammatory potency of cortisol. In acute musculoskeletal injury research, short course corticosteroids are studied for rapid inflammation reduction particularly in tendinopathy, bursitis, and joint inflammation research. Long term corticosteroid use is associated with significant adverse effects including muscle wasting, immune suppression, and HPA axis suppression. Making appropriate protocol design critical in corticosteroid research.
NSAIDs | Meloxicam and Diclofenac
Non steroidal anti inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) enzymes. Reducing prostaglandin synthesis and producing analgesic, anti inflammatory, and antipyretic effects. Meloxicam is a preferential COX-2 inhibitor with a superior gastrointestinal safety profile compared to non selective NSAIDs, making it one of the most widely researched NSAIDs for chronic musculoskeletal inflammation management. Diclofenac is available in both oral and topical formulations; topical Diclofenac gel achieves local anti inflammatory concentrations in musculoskeletal tissue with minimal systemic exposure, reducing gastrointestinal and cardiovascular risks associated with systemic NSAID use. Both are stocked by CSD for acute and chronic inflammation research applications.
Frequently asked questions
CSD stocks BPC-157, TB-500, BPC-157 + TB-500 stack, MK-2866 (Ostarine), Ipamorelin, Dexamethasone, Methylprednisolone, Meloxicam, Diclofenac (oral and topical), and more. Check the category page for current availability and stock status.
BPC-157 acts primarily through local tissue mechanisms, upregulating growth hormone receptors, stimulating VEGF mediated angiogenesis, and modulating nitric oxide production at the injury site. It demonstrates particularly strong effects on tendon to bone healing, gut tissue repair, and nerve regeneration. TB-500 acts more systemically through actin regulation and cell migration promotion, with particular relevance to muscle fibre repair and vascular remodeling. The two compounds are complementary and are frequently researched in combination for synergistic tissue repair effects.
BPC-157 is most commonly administered subcutaneously or intramuscularly. Either systemically or locally near the injury site. Systemic subcutaneous administration produces body-wide tissue repair effects, while local injection near the injury site may concentrate effects at the target tissue. BPC-157 is also available in nasal spray format for systemic delivery via intranasal absorption. Typical research protocols use 250–500mcg per day administered once or twice daily.
Research suggests that chronic high dose NSAID use may impair satellite cell activity and muscle protein synthesis. Potentially slowing long term muscle repair and adaptation. Short term NSAID use for acute inflammation management is generally considered acceptable in research contexts. Preferential COX-2 inhibitors such as Meloxicam produce less prostaglandin suppression in muscle tissue than non selective NSAIDs and are preferred where anti inflammatory effects are needed without maximal impact on muscle repair signaling.
Ostarine demonstrates significant anabolic activity in muscle and bone tissue at relatively low doses. Clinical trials have shown meaningful lean mass preservation and increases even in catabolic conditions such as cancer cachexia. For injury recovery research where muscle atrophy prevention during immobilization is the objective, Ostarine is one of the most studied selective compounds available, offering anabolic effects without the full androgenic activity and associated side effects of traditional anabolic steroids.
All orders ship from within Canada via tracked Canada Post or courier. Peptide compounds are shipped in insulated packaging to maintain temperature stability during transit. Packages are plain and discreet with no identifying product information on the exterior. Most orders arrive within 2–5 business days depending on your province. Express shipping is available at checkout. Orders over $250 qualify for free shipping Canada wide.